Tengjun Competitors

Delisted . USA . 
Stock . Tengjun Biotechnology Corp
TJBHDelisted Stock  USD 2.00  0.00  0.00%   
Tengjun Biotechnology competes with South Dakota, Want Want, Dundee Corp, Casino Guichard-Perrach, and Warpaint London; as well as few others. The company conducts business under Consumer Defensive sector and is part of Packaged Foods industry. Analyzing Tengjun Biotechnology competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Tengjun Biotechnology to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Tengjun Biotechnology vs Stevia Nutra Correlation

Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
2.002.002.00
Details
Intrinsic
Valuation
LowRealHigh
1.701.702.20
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tengjun Biotechnology. Your research has to be compared to or analyzed against Tengjun Biotechnology's peers to derive any actionable benefits. When done correctly, Tengjun Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tengjun Biotechnology.

Tengjun Biotechnology Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Tengjun Biotechnology and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Tengjun and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Tengjun Biotechnology does not affect the price movement of the other competitor.

High positive correlations

DDEJF
+ 0.83
SDSYA
ADWPF
+ 0.72
SDSYA
CGUIF
+ 0.51
WWNTY
ADWPF
+ 0.51
DDEJF
WPNTF
+ 0.47
WWNTY
WPNTF
+ 0.34
CGUIF
  

High negative correlations

CGUIF
- 0.66
DDEJF
CGUIF
- 0.66
SDSYA
ADWPF
- 0.56
CGUIF
WPNTF
- 0.47
DDEJF
WWNTY
- 0.33
SDSYA
WPNTF
- 0.26
SDSYA

Risk-Adjusted Indicators

There is a big difference between Tengjun OTC Stock performing well and Tengjun Biotechnology OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tengjun Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SDSYA  0.29  0.16  0.00 (0.54) 0.00 
 0.00 
 0.00 
 0.00 
 7.14 
WWNTY  0.94 (0.05) 0.00 (1.06) 0.00 
 0.00 
 3.33 
(5.35)
 16.59 
DDEJF  2.58  0.58  0.12 (1.18) 3.31 
(2.84)
 4.61 
(5.39)
 16.43 
CGUIF  1.47 (0.82) 0.00 (0.90) 0.00 
 0.00 
 0.00 
 0.00 
 49.09 
SHGXY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
WPNTF  1.84 (1.02) 0.00 (0.95) 0.00 
 0.00 
 0.00 
 0.00 
 59.68 
ADWPF  0.42  0.06  0.00  0.47  0.00 
 0.00 
 1.96 
(1.30)
 6.44 
CVNZF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BUBSF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
STNT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 

Tengjun Biotechnology Competitive Analysis

The better you understand Tengjun Biotechnology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Tengjun Biotechnology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Tengjun Biotechnology's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
TJBH SDSYA WWNTY DDEJF CGUIF SHGXY WPNTF ADWPF CVNZF BUBSF
 0.00 
 2.00 
Tengjun
 0.00 
 7.50 
South
 1.68 
 30.48 
Want
 4.61 
 3.18 
Dundee
 0.00 
 0.28 
Casino
 0.00 
 0.66 
Shenguan
 0.00 
 2.50 
Warpaint
 2.39 
 3.85 
Andrew
 0.00 
 0.46 
Comvita
 0.00 
 0.09 
Bubs
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Unstable
Out of control
Very steady
Dangerous
Somewhat reliable
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Good
Weakest
Good
Weakest
Weakest
Weakest
Fair
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Low
Low
Low
Small
Hazard
Low
Moderate
Hazard
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Hold
Cautious Hold
Not Rated
Strong Sell
Current Ratio
0.7
1.19
1.79
7.86
0.82
2.2
3.79
5.52
3.8
2.26
Net Asset
14.03 M
245.29 M
29.86 B
358.19 M
30.54 B
3.31 B
47.57 M
558.07 M
332.78 M
125.94 M
Profit Margin
0.0795
0.0836
0.16
-1.73
-0.0179
0.0686
0.0953
-9.0E-4
0.0612
-0.13
EBITDA
(424.11 K)
17.83 M
6.84 B
(85.14 M)
1.82 B
168.32 M
7.55 M
47.77 M
30.66 M
(7.82 M)
Operating Margin
0.1
0.0835
0.19
-1.92
0.0377
0.0583
0.11
0.0424
0.096
-0.12
Current Valuation
385.53 M
168.64 M
6.93 B
121.62 M
14.94 B
70.61 M
179.44 M
321.02 M
307.29 M
148.93 M
Price To Book
50.08
N/A
3.32
0.51
0.44
0.31
3.53
0.85
0.85
4.37
Retained Earnings
N/A
N/A
17.27 B
596.59 M
4.66 B
2.71 B
N/A
N/A
27 M
N/A
Current Asset
N/A
N/A
14.34 B
N/A
13.13 B
1.75 B
N/A
N/A
110 M
N/A
Five Year Return
N/A
N/A
2.44
N/A
5.42
N/A
N/A
N/A
N/A
N/A
Beta
2.53
0.19
0.56
1.5
0.99
0.42
0.98
0.56
0.82
0.57
Number Of Employees
19
116
41.04 K
24
196.31 K
2.65 K
113
1.62 K
550
65
Shares Outstanding
96.31 M
30.42 M
237.68 M
84.97 M
108.09 M
161.52 M
76.75 M
35.04 M
69.73 M
751.36 M
Cash Flow From Operations
(561.3 K)
18.02 M
3.91 B
(10.67 M)
1.53 B
179.71 M
5.09 M
15.59 M
2.83 M
(9.37 M)
Annual Yield
N/A
N/A
0.0486
0.14
0.0894
0.0672
0.0353
0.0485
0.0215
N/A
Total Debt
301.43 K
13.99 M
3.55 B
5 M
7.45 B
534.96 M
3.32 M
192.06 M
43.3 M
4.92 M
Return On Equity
2.01
0.45
0.25
-0.0743
-0.0737
0.0282
0.15
-0.0013
0.0568
-0.13
Z Score
N/A
11.6
1.2
11.6
1.0
N/A
30.4
N/A
1.8
18.0
Return On Asset
0.34
0.12
0.1
-0.0413
0.0242
0.0121
0.0765
0.0183
0.0405
-0.0591
Book Value Per Share
0.085
4.85
57.55
2.82
25.43
15.54
0.51
6.16
3.27
0.14
Current Liabilities
N/A
N/A
6.8 B
N/A
13.6 B
568 M
N/A
N/A
30 M
N/A
Total Asset
14.03 M
245.29 M
29.86 B
358.19 M
30.54 B
3.31 B
47.57 M
558.07 M
332.78 M
125.94 M
Debt To Equity
N/A
0.76
0.42
0.028
2.3
0.21
0.094
0.78
0.25
0.055
Last Dividend Paid
N/A
0.57
0.21
N/A
N/A
0.016
0.061
0.25
0.055
N/A
Shares Owned By Institutions
N/A
N/A
N/A
24.19
27.1
N/A
37.36
2.0
10.27
3.67
Market Capitalization
595.19 M
236.36 M
8.01 B
87.75 M
1.33 B
139.94 M
162.71 M
169.46 M
148.12 M
151.19 M
Price To Earning
N/A
15.14
13.33
1.75
37.63
5.81
302.86
5.75
22.41
N/A
Price To Earnings To Growth
N/A
N/A
2.8
N/A
0.34
N/A
N/A
N/A
N/A
N/A
Price To Sales
4.19
0.34
0.34
7.18
0.0373
0.12
2.87
0.43
0.67
2.92
Net Income
(747.52 K)
28.01 M
4.2 B
(93.02 M)
(530 M)
122.65 M
2.83 M
12.47 M
12.78 M
(11.38 M)
Earnings Per Share
0.09
0.7
2.25
-0.4
-5.49
0.07
0.01
0.21
0.11
-0.071
Shares Owned By Insiders
53.02
2.28
N/A
15.61
44.46
N/A
51.24
15.5
39.3
19.75
Revenue
N/A
590.15 M
23.98 B
18.45 M
31.05 B
1.17 B
50 M
373.94 M
209.09 M
89.3 M
Working Capital
N/A
N/A
7.53 B
N/A
(469 M)
1.19 B
N/A
N/A
80 M
N/A
Cash And Equivalents
6.76 M
3.83 M
11.29 B
66.05 M
2.13 B
866.53 M
6.72 M
1.43 M
17.76 M
16.31 M
Cash Per Share
0.08
0.13
47.44
0.75
19.76
5.36
0.09
0.03
0.25
0.02
Gross Profit
N/A
33.47 M
10.75 B
8.37 M
7.62 B
310.49 M
16.91 M
138.99 M
126 M
28.91 M
Day Typical Price
2.0
7.5
30.48
3.18
0.28
0.66
2.5
3.85
0.46
0.0923
Accumulation Distribution
N/A
N/A
N/A
0.0031
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
N/A
0.01
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.0
0
14.0
0.0
0.0
0.0
9.2 T
0.0
0.0
Period Momentum Indicator
N/A
N/A
(0.52)
0.14
N/A
N/A
N/A
0.09
N/A
N/A
Rate Of Daily Change
1.0
1.0
0.98
1.05
1.0
1.0
1.0
1.02
1.0
1.0
Day Median Price
2.0
7.5
30.48
3.18
0.28
0.66
2.5
3.85
0.46
0.0923
Price Action Indicator
N/A
N/A
(0.26)
0.075
N/A
N/A
N/A
0.045
N/A
N/A
Coefficient Of Variation
N/A
627.43
(6,851)
584.09
(812.40)
N/A
(800.00)
1112.31
N/A
N/A
Mean Deviation
N/A
0.2913
0.9392
2.58
1.47
N/A
1.84
0.4247
N/A
N/A
Jensen Alpha
N/A
0.1611
(0.05)
0.5824
(0.82)
N/A
(1.02)
0.0632
N/A
N/A
Total Risk Alpha
N/A
0.0471
(0.29)
0.2247
(1.35)
N/A
(1.68)
(0.02)
N/A
N/A
Sortino Ratio
N/A
N/A
N/A
0.1238
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
14.16
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
N/A
0.9445
2.44
3.24
6.04
N/A
7.46
0.9583
N/A
N/A
Kurtosis
N/A
51.59
8.01
1.22
66.0
N/A
64.0
9.4
N/A
N/A
Potential Upside
N/A
N/A
3.33
4.61
N/A
N/A
N/A
1.96
N/A
N/A
Treynor Ratio
N/A
(0.54)
(1.06)
(1.18)
(0.90)
N/A
(0.95)
0.4683
N/A
N/A
Maximum Drawdown
N/A
7.14
16.59
16.43
49.09
N/A
59.68
6.44
N/A
N/A
Variance
N/A
0.892
5.96
10.53
36.51
N/A
55.65
0.9183
N/A
N/A
Market Risk Adjusted Performance
N/A
(0.53)
(1.05)
(1.17)
(0.89)
N/A
(0.94)
0.4783
N/A
N/A
Risk Adjusted Performance
N/A
0.1299
(0.01)
0.1455
(0.09)
N/A
(0.09)
0.074
N/A
N/A
Skewness
N/A
7.04
0.8004
(0.91)
(8.12)
N/A
(8.00)
0.9062
N/A
N/A
Semi Deviation
N/A
N/A
N/A
3.31
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
N/A
0.0644
(0.05)
0.1436
(0.14)
N/A
(0.14)
(0)
N/A
N/A
Value At Risk
N/A
N/A
(5.35)
(5.39)
N/A
N/A
N/A
(1.30)
N/A
N/A
Expected Short fall
N/A
N/A
N/A
(2.84)
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
3.76
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
10.97
N/A
N/A
N/A
N/A
N/A
N/A

Tengjun Biotechnology Competition Performance Charts

Five steps to successful analysis of Tengjun Biotechnology Competition

Tengjun Biotechnology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Tengjun Biotechnology in relation to its competition. Tengjun Biotechnology's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Tengjun Biotechnology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Tengjun Biotechnology's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Tengjun Biotechnology, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Tengjun Biotechnology position

In addition to having Tengjun Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Junk Bonds Funds Thematic Idea Now

Junk Bonds Funds
Junk Bonds Funds Theme
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Tengjun Biotechnology information on this page should be used as a complementary analysis to other Tengjun Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Tengjun OTC Stock

If you are still planning to invest in Tengjun Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tengjun Biotechnology's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY